Phase 3 clinical study of AFT-801(confirmatory study 0305) Double-blind, placebo-controlled study for excessive daytime sleepiness accompanying obstructive sleep apnea syndrome in CPAP-treated patients
Latest Information Update: 06 Jun 2016
At a glance
- Drugs Modafinil (Primary)
- Indications Sleep apnoea syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 06 Jun 2016 New trial record